Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months

F.M. Russell, A. Balloch, P.V. Licciardi, Jonathan Carapetis, L. Tikoduadua, L. Waqatakirewa, Y.B. Cheung, E.K. Mulholland, M.L.K. Tang

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)
Original languageEnglish
Pages (from-to)4499-4506
JournalVaccine
Volume29
Issue number27
DOIs
Publication statusPublished - 2011

Cite this